| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $9.9B | — | — | — | — |
| Op. Income | $1.8B | — | — | — | — |
| Gross Margin | 100.0% | — | — | — | — |
| Net Margin | 6.9% | — | — | — | — |
| EPS (Diluted) | $1.10 | — | — | — | — |
| Free Cash Flow | $0 | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $9.9B |
| Cost of Revenue | $0 |
| GROSS PROFIT | $9.9B |
| R&D Expenses | $0 |
| Selling & Marketing | $885M |
| General & Administrative | $459M |
| SG&A Expenses | $1.3B |
| Other Expenses | $6.7B |
| Operating Expenses | $8.1B |
| Cost & Expenses | $8.1B |
| OPERATING INCOME | $1.8B |
| Interest Income | $5.3B |
| Interest Expense | $72M |
| Other Income/Expenses | -$36M |
| INCOME BEFORE TAX | $1.8B |
| Income Tax Expense | $592M |
| Net Income from Continuing Ops | $1.2B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $684M |
| Net Income Deductions | -$24M |
| BOTTOM LINE NET INCOME | $684M |
| D&A | $0 |
| EBIT | $1.8B |
| EBITDA | $1.8B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $9.9B |
| Cost of Revenue | $0 |
| GROSS PROFIT | $9.9B |
| R&D Expenses | $0 |
| Selling & Marketing | $885M |
| General & Administrative | $459M |
| SG&A Expenses | $1.3B |
| Other Expenses | $6.7B |
| Operating Expenses | $8.1B |
| Cost & Expenses | $8.1B |
| OPERATING INCOME | $1.8B |
| Interest Income | $5.3B |
| Interest Expense | $72M |
| Other Income/Expenses | -$36M |
| INCOME BEFORE TAX | $1.8B |
| Income Tax Expense | $592M |
| Net Income from Continuing Ops | $1.2B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $684M |
| Net Income Deductions | -$24M |
| BOTTOM LINE NET INCOME | $684M |
| D&A | $0 |
| EBIT | $1.8B |
| EBITDA | $1.8B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $684M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $248M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$932M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $0 |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $0 |
| Net Change in Cash | -$21.2B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $20.6B |
| Short-Term Investments | $0 |
| Net Receivables | $10.9B |
| Inventory | $0 |
| Other Current Assets | -$31.5B |
| TOTAL CURRENT ASSETS | $0 |
| PP&E (Net) | $0 |
| Goodwill | $5.9B |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | -$5.9B |
| TOTAL NON-CURRENT ASSETS | $0 |
| TOTAL ASSETS | $460.9B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $376.0B |
| TOTAL CURRENT LIABILITIES | $376.0B |
| Long-Term Debt | $13.4B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | -$13.4B |
| TOTAL NON-CURRENT LIABILITIES | $0 |
| TOTAL LIABILITIES | $418.4B |
| Common Stock | $0 |
| Additional Paid-In Capital | $17.0B |
| Retained Earnings | $7.6B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$2.6B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $23.3B |
| Minority Interest | $19.2B |
| TOTAL EQUITY | $42.5B |
| TOTAL LIABILITIES & EQUITY | $460.9B |
| Total Debt | $13.4B |
| Net Debt | -$7.2B |
